Background: Cystic fibrosis-related diabetes (CFRD) is believed to be associated with faster decline in pulmonary functions and with higher morbidity and mortality in cystic fibrosis (CF) patients. However, accurate matched patient control studies are missing. We investigated retrospectively the decline in pulmonary functions and BMI in patients with CFRD in comparison with matched CF patients without diabetes. Methods: 27 patients with insulin dependent CFRD and good diabetic management (median HbA1c = 6.6) were matched with 27 CF patients without diabetes according to gender, age, BMI, class of mutation, FEV1% predicted and infection status. Over a period of 5 years the following parameters were studied: FEV1% predicted, FVC% predicted, BMI and in-hospital days. Results: At the start of this study, no differences between both patient groups were seen. Over a period of 5 years, both groups showed a remarkable decline in pulmonary functions. The rate of decline for FEV1% predicted was significantly higher in CFRD patients (2.2% decline/year vs. 1.4% decline/year, p = 0.049), though this difference was not significant for FVC% predicted. CFRD patients tended to spend more days in hospital. BMI remained unchanged in both groups. Conclusion: After 5 years, differences were found between CFRD patients and CF patients without diabetes for FEV1 and in-hospital days, however not for FVC and BMI. Unlike other studies, patients were properly matched and had good diabetic control. This study shows that the clinical impact of CFRD is certainly present, but probably smaller than originally presumed. Low BMD is common in CF, yet there are few longitudinal studies of the determinants of loss of bone mineral in adults with CF. This study aimed to measure changes in BMD in CF adults over 3 years; and to identify clinical correlates of loss of BMD. Methods: Data were analysed from 47 adults with CF (55% male, mean age at baseline 29.9±6.9 years) who had not received bisphosphonate or hormone replacement therapy. Lumbar spine (LS) and femoral neck (FN) BMD and body composition (lean tissue mass, LTM) were assessed using DXA scanning at baseline and followup (mean 3.3±0.6 years later). Changes (DLSBMD, DFNBMD and DLTM) were expressed as annual %change from baseline (ann%D 
